Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
Mirna M, Holnthoner M, Topf A, Jirak P, Fejzic D, Paar V, Kellermair J, Blessberger H, Reiter C, Kammler J, Motloch LJ, Jung C, Kretzschmar D, Franz M, Alushi B, Lauten A, Hoppe UC, Steinwender C, Lichtenauer M.
Mirna M, et al. Among authors: reiter c.
J Clin Lab Anal. 2021 Nov;35(11):e23977. doi: 10.1002/jcla.23977. Epub 2021 Sep 25.
J Clin Lab Anal. 2021.
PMID: 34562276
Free PMC article.